A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MS

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

1983 • 7,404 citations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

1996 • 2,410 citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1976 • 2,290 citations

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1998 • 2,049 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 2,032 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 1,908 citations

Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

2000 • 1,497 citations

Relapses and Progression of Disability in Multiple Sclerosis

2000 • 1,285 citations

Interferon beta‐lb in the treatment of multiple sclerosis

1995 • 899 citations

Minimization: A new method of assigning patients to treatment and control groups

1974 • 837 citations

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS

1999 • 728 citations

PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MS

2001 • 563 citations

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

2001 • 471 citations

Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis

1998 • 334 citations

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis

1998 • 332 citations

Neuropsychological effects of interferon ?-1a in relapsing multiple sclerosis

2000 • 292 citations

Quantification of MRI lesion load in multiple sclerosis: A comparison of three computer-assisted techniques

1996 • 207 citations

Evidence of interferon β-1a dose response in relapsing-remitting MS

1999 • 201 citations

Allocation of patients to treatment groups in a controlled clinical study

1978 • 190 citations

Neuropsychological effects of interferon β‐1a in relapsing multiple sclerosis

2000 • 167 citations

Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques

1998 • 57 citations

Interferon-Beta in the Treatment of Multiple Sclerosis

2001 • 26 citations

Treatment of Multiple Sclerosis with Interferons

1992 • 13 citations

Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX) : rationale, design and baseline data

2001 • 8 citations

Double-blind randomized multicenter dose-comparison study of interferon-β-1a (AVONEX): rationale, design and baseline data

2001 • 6 citations